Therapeutic implications of acquired high tumor mutational burden (TMB-H) after targeted therapy (TT) in metastatic colorectal cancer (mCRC) Meeting Abstract
| Authors: | Yeh, C.; Harrold, E.; Keane, F.; Sinopoli, J. C.; Foote, M. B.; Cercek, A.; Yaeger, R. |
| Abstract Title: | Therapeutic implications of acquired high tumor mutational burden (TMB-H) after targeted therapy (TT) in metastatic colorectal cancer (mCRC) |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557400797 |
| PROVIDER: | wos |
| DOI: | 0.1200/JCO.2024.42.16_suppl.3542 |
| Notes: | Meeting Abstract: 3542 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
